The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer

British Journal of Cancer

Volumn 73, Issue 3, 1996, Pages 301-306

  Bartlett, J M S ^a,e   Langdon, S P ^a   Simpson, B J B ^a   Stewart, M ^a   Katsaros, D ^b   Sismondi, P ^b   Love, S ^c   Scott, W N ^a   Williams, A R W ^d   Lessells, A M ^a   Macleod, K G ^a   Smyth, J F ^a   Miller, W R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF TURIN   (Italy)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Epidermal growth factor receptor; Ovarian cancer; Reverse transcriptase polymerase chain reaction

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CANCER GROWTH; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 9044251203     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.53     Document Type: Article

References (28)

1. BARTLETT JMS, RABIASZ GM, SCOTT WN, LANGDON SP, SMYTH JF AND MILLER WR. (1992). Transforming growth factor-β mRNA expression and growth control of human ovarian carcinoma cells. Br. J. Cancer. 65, 655-660.
2. BATTAGLIA F, SCAMBIA G, BENEDITTI PANICI P, BAIOCCHI G, PERRONI L, IACOBELLI S AND NANCUROS S. (1989). Epidermal growth factor expression in gynecological malignancies. Gynecol. Obstet. Invest., 27, 42-44.
3. BAUKNECHT T, RUNGE M, SCHWALL M AND PFLEIDERER A. (1988). Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomas. Gynecol. Oncol., 29, 147-157.
4. BAUKNECHT T, BIRMELIN G AND KOMMOSS F. (1990). Clinical significance of oncogenes and growth factors in ovarian carcinomas. J. Ster. Biochem. Mol. Biol., 37, 855-862.
5. BAUKNECHT T, ANGEL P, KOHLER M, KOMMOSS F, BIRMELIN G, PFLEIDERER A AND WAGNER E. (1993). Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor alpha, myc, jun and metallothionein in human ovarian carcinomas: classification of malignant phenotypes. Cancer, 71, 419-429.
6. BERCHUCK A, RODRIGUEZ GC, KAMEL A, DODGE RK, SOPER JT, CLARKE-PEARSON DL AND BAST RC. (1991). Epidermal growth factor expression in normal ovarian epithelium and ovarian cancer. Am. J. Obstet. Gynecol., 164, 669-674.
7. BERCHUCK A AND BAST RC JR. (1993). Growth factors, oncogenes and tumor suppressor genes. In Cancer of the Ovary. Markman M and Hoskins WJ (eds) pp. 61-78. Raven Press: New York.
8. BERNS EMJJ, KLIJN JGM, HENZEN-LOGMANS SC, RODENBURG CJ AND VAN DER BURG MEL. (1992). Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer. Int. J. Cancer. 52, 218-224.
9. CANNISTRA SA. (1993). Cancer of the ovary. N. Engl. J. Med., 329, 1550-1559.
10. COX DR. (1972). Regression models and life tables. J. R. Stat. Soc. (B), 34, 187-220.
11. CREW AJ, LANGDON SP, MILLER EP AND MILLER WR. (1992). Mitogenic effects of epidermal growth factor and transforming growth factor-α on EGF-receptor positive human ovarian carcinoma cell lines. Eur. J. Cancer, 28, 337-341.
12. FOEKENS JA, VAN-PUTTEN WL, PORTENGEN H, RODENBURG CJ, REUBI JC, BERNS PM, HENZEN-LOGMANS SC, VAN DER BURG ME, ALEXIEVA-FIGUSH J AND KLIJN JG. (1990). Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor I (IGF-1-R) and somatostatin in patients with breast and ovarian cancer. J. Ster. Biochem. Mol. Biol., 37, 815-821.
13. HENZEN-LOGMANS SC, BERNS EMJJ, KLIJN JGM, VAN DER BURG MEL AND FOEKENS JA. (1992). Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay. Br. J. Cancer, 66, 1015-1021.
14. INTERNATIONAL FEDERATlON OF GYNECOLOGY AND OBSTETRICS. (1987). Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am. J. Obstet. Gynecol., 156, 263-264.
15. JINDAL SK, SNOEY DM, LOBB DK AND DORRINGTON JH. (1994). Transforming growth factor alpha localization and role in surface epithelium of normal human ovaries and in ovarian carcinoma cells. Gynecol. Oncol., 53, 17-23.
16. KOHLER M, BAUKNECHT T, GRIMM M, BIRMELIN G, KOMMOSS F AND WAGNER E. (1992). Epidermal growth factor receptor (EGF-R) and transforming growth factor alpha (TGF-α) expression in human ovarian carcinomas. Eur. J. Cancer, 8-9, 1432-1437.
17. LA VECCHIA C, LUCCHINI F, NEGRI E, BOYLE P, MAISONNEUVE P AND LEVI F. (1992). Trends of cancer mortality in Europe, 1955-1989: III, breast and genital sites. Eur. J. Cancer, 28A, 927-998.
18. MORISHIGE K, KURACHI H, AMEMIYA K, FUJITA Y, YAMAMOTO T, MIYAKE A AND TANIZAWA O. (1991). Evidence for the involvement of transforming growth factor-α and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro. Cancer Res., 51, 5322-5328.
19. OWENS OJ AND LEAKE RE. (1993). Epidermal growth factor receptor expression in malignant ovary, benign ovarian tumours and normal ovary: a comparison. Int. J. Cancer, 2, 321-324.
20. OWENS OJ, STEWART C, BROWN I AND LEAKE RE. (1991). Epidermal growth factor receptors (EGFR) in human ovarian cancer. Br. J. Cancer, 64, 907-910.
21. OWENS OJ, STEWART C AND LEAKE RE. (1991). Growth factors in ovarian cancer. Br. J. Cancer, 64, 1177-1181.
22. OWENS OJ, STEWART C, LEAKE RE AND McNICOL AM. (1992). A comparison of biochemical and immunohistochemical assessment of EGFr expression in ovarian cancer. Anticancer Res., 12, 1455-1458.
23. RODRIGUEZ GC, BERCHUCK A, WHITAKER RS, SCHLOSSMAN D, CLARKE-PEARSON DL AND BAST RC. (1991). Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. 2. Relationship between receptor expression and response to epidermal growth factor. Am. J. Obstet. Gynecol., 164, 745-750.
24. SCAMBIA G, BENEDETTI-PANICI P, BATTAGLIA F, FERRANDINA G, GAGGINI C AND MANCUSO S. (1991). Presence of epidermal growth factor (EGF) receptor and proliferative response to EGF in six human ovarian carcinoma cell lines. Int. J. Gynecol. Cancer, 1, 253-258.
25. SCAMBIA G, BENEDETTI-PANICI P, BATTAGLIA F, FERRANDINA G, BAIOCCHI G, GREGGI S, DE VINCENZO R AND MANCUSO S. (1992). Significance of epidermal growth factor receptor in advanced ovarian cancer. J. Clin. Oncol., 10, 529-535.
26. SEROV S AND SCULLY RE. (1973). Histological typing of ovarian tumors. In International Histological Classification of Tumors, no 9, World Health Organization: Geneva.
27. VAN DER BURG MEL, HENZEN-LOGMANS SC, FOEKENS JA, BERNS EMJJ, RODENBURG CJ, VAN PUTTEN WLJ AND KLIJN JGM. (1993). The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study. Eur. J. Cancer, 29A, 1951-1957.
28. ZHOU L AND LEUNG BS. (1992). Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factors α and β1. Biochim. Biophys. Acta, 1180, 130-136.